n-(1-methyl-2-phenylethyl)adenosine has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 1 studies
Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Trials ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) | Recent Studies (post-2010) ((4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride) |
---|---|---|---|---|---|
134 | 0 | 4 | 285 | 0 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Correia-de-Sá, P; Oliveira, L; Timóteo, MA | 1 |
1 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
Article | Year |
---|---|
Negative crosstalk between M1 and M2 muscarinic autoreceptors involves endogenous adenosine activating A1 receptors at the rat motor endplate.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Adenosine; Adenosine A1 Receptor Agonists; Adenosine Deaminase; Animals; Female; Male; Motor Endplate; Neurotransmitter Agents; Nucleoside Transport Proteins; Oxotremorine; Phrenic Nerve; Pirenzepine; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Thioinosine; Tritium; Xanthines | 2009 |